Study Stopped
Only 1 participant recruited to study. Qs addressed in other ongoing studies.
Internet-Based Relapse Prevention vs Face to Face Therapy at an Employee Assistance Program
FoBeMA
1 other identifier
interventional
1
1 country
1
Brief Summary
Objectives: This study will evaluate the efficacy of internet-based relapse prevention with therapist support, as compared to face-to-face therapy at an employee assistance program. The design is a two-armed randomized controlled design, and outcomes are measured in terms of changes in problematic alcohol use, as well as depression and quality of life. Method: Participants with problematic alcohol use who, after an initial evaluation consisting of five face-to-face sessions with a licensed psychologist where alcohol and collateral problems are extensively assessed, are recommended treatment for problematic alcohol use. Consenting participants will be randomized into one of two groups: 1. Internet delivered relapse prevention with therapist support or 2. Face-to-face therapy. Outcomes on alcohol use, depression and quality of life as well as information on user satisfaction will be gathered post treatment. Follow up will be at 3, 6 and 12 months after completion. Our hypothesis is that the internet-based program with therapist support and the face-to-face therapy will be equally effective in reducing alcohol use (non-inferiority).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2013
CompletedFirst Posted
Study publicly available on registry
December 18, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedMarch 15, 2016
March 1, 2016
2.2 years
December 12, 2013
March 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Alcohol Use Identification Test (AUDIT)
Change in total AUDIT score, as a summarized measure of alcohol use (including alcohol consumption and alcohol-related problems)
Post, 3, 6 and 12 months
Secondary Outcomes (3)
Time Line Follow Back (TLFB)
Post, 3, 6 and 12 months
Montgomery Asberg Depression Rating Scale - Self report (MADRS-S)
Post, 3, 6 and 12 months
World Health Quality of Life Scale (WHOQOL-BREF)
Post, 3, 6 and 12 months
Other Outcomes (2)
Drug Use Identification Test (DUDIT)
Post, 3, 6 and 12 months
Biological tests for alcohol markers
Post
Study Arms (2)
eChange web-based relapse prevention
EXPERIMENTALA relapse intervention program consisting of 14 modules. Patients will have access to therapist support through an internal secure messaging system.
Face-to-face therapy
ACTIVE COMPARATORFace-to-face psychotherapy, consisting of 20 sessions. The content will be vary for different therapists, but all have an evidence-based approach to therapy
Interventions
A web-based relapse intervention program consisting of 14 modules. The patient will have access to therapist support through a secure messaging system
Face-to-face psychotherapy, consisting of 20 sessions. The content will be different for different therapists, but all have an evidence based approach to therapy
Eligibility Criteria
You may qualify if:
- Problematic alcohol use and having been recommended psychotherapy by the assessing psychologist.
You may not qualify if:
- Inadequate Swedish language skills No Internet access Reading and/or writing difficulties Major depression Current suicidal thoughts and/or plans Primary problematic drug use PTSD-related problems Psychosis Cognitive disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska institutet, Department of Clinical Neuroscience
Stockholm, 171 76, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne H Berman, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 12, 2013
First Posted
December 18, 2013
Study Start
January 1, 2014
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
March 15, 2016
Record last verified: 2016-03